{
    "clinical_study": {
        "@rank": "63842", 
        "arm_group": [
            {
                "arm_group_label": "EVERA", 
                "arm_group_type": "Experimental", 
                "description": "EVERA- korean ESTES system, apply for 12 weeks"
            }, 
            {
                "arm_group_label": "ESTES", 
                "arm_group_type": "Active Comparator", 
                "description": "ESTES apply for 12 weeks"
            }
        ], 
        "brief_summary": {
            "textblock": "Expected Total Number of Subjects\n\n        -  Level of significance, alfa 0.05\n\n        -  Power 0.80\n\n        -  Mean difference between two treatments is assumed 35\n\n        -  Standard Deviation is assumed 35.\n\n        -  Follow-up loss is assumed 20%\n\n        -  N=34(each group:17)"
        }, 
        "brief_title": "Efficacy and Safety Study of EVERA to Augment Small Breast", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Atrophy of Breast", 
        "condition_browse": {
            "mesh_term": "Atrophy"
        }, 
        "detailed_description": {
            "textblock": "Study design\n\n        -  single center, randomized, unblind clinical study Medical device\n\n        -  Investigational Medical Device: EVERA\n\n        -  Comparator:  ESTES Process\n\n        -  For eligible subjects, investigator apply Standard Deviation or Comparator on the\n           breast\n\n        -  The  Investigational Medical Device  is determined by randomization.\n\n        -  Subjects will be applied  for 12 weeks.\n\n        -  Subjects will receive Patient Compliance Diary\n\n        -  Subjects will visit the hospital to measure breast volume with VIVID 9i every 2 weeks\n           for 16weeks"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Female aged between 24 and 40\n\n          -  BMI of over 20\n\n          -  Subjects who want to augment breasts\n\n          -  Subjects who understand the study contents and signed the informed consent\n\n          -  Subjects who can follow study procedure\n\n        Exclusion Criteria:\n\n          -  Pregnant or Lactating subjects"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "40 Years", 
            "minimum_age": "24 Years"
        }, 
        "enrollment": {
            "#text": "34", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 6, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02009137", 
            "org_study_id": "E1307-210-002", 
            "secondary_id": "06-2013-175-GNSD"
        }, 
        "intervention": [
            {
                "arm_group_label": "EVERA", 
                "description": "EVERA apply for 12 weeks", 
                "intervention_name": "EVERA", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "ESTES", 
                "description": "ESTES apply for 12 weeks", 
                "intervention_name": "ESTES", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "small breast", 
            "augmentation", 
            "breast volume", 
            "External Soft Tissue Expansion System(ESTES)"
        ], 
        "lastchanged_date": "June 1, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Seongnam-si", 
                    "country": "Korea, Republic of", 
                    "state": "Gumi-dong, Bundang-gu/Gyeonggi-do", 
                    "zip": "463-707"
                }, 
                "name": "Seoul National Univ. Bundang Hospital"
            }
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Breast Augmentation Using EVERA - Comparative Clinical Trial With ESTES", 
        "overall_official": {
            "affiliation": "Seoul National University Bundang Hospital", 
            "last_name": "Chanyeong - Heo, Ph.D", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Korea: Ministry of Education, Science, and Technology", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "The change in breast volume of the test group and control group", 
            "safety_issue": "No", 
            "time_frame": "Baseline and 12weeks and 16weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02009137"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Seoul National University Hospital", 
            "investigator_full_name": "Chan-Yeong Heo", 
            "investigator_title": "Assistant Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Changes in satisfaction level on their breast", 
            "safety_issue": "No", 
            "time_frame": "Baseline and 12weeks and 16 weeks"
        }, 
        "source": "Seoul National University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Seoul National University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2014"
    }
}